Objectives To apply a statistical clustering algorithm to combine information from dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) into a single tumour map to distinguish high-grade from low-grade T1b clear cell renal cell carcinoma (ccRCC). Methods This prospective, Institutional Review Board -approved, Health Insurance Portability and Accountability Act -compliant study included 18 patients with solid T1b ccRCC who underwent presurgical DCE MRI. After statistical clustering of the parametric maps of the transfer constant between the intravascular and extravascular space (K trans ), rate constant (K ep ) and initial area under the concentration curve (iAUC) with a fuzzy c-means (FCM) algorithm, each tumour was segmented into three regions (low/medium/ high active areas). Percentages of each region and tumour size were compared to tumour grade at histopathology. A decision-tree model was constructed to select the best parameter(s) to predict high-grade ccRCC. Results Seven high-grade and 11 low-grade T1b ccRCCs were included. High-grade histology was associated with higher percent high active areas (p = 0.0154) and this was the only feature selected by the decision tree model, which had a diagnostic performance of 78% accuracy, 86% sensitivity, 73% specificity, 67% positive predictive value and 89% negative predictive value. Conclusions The FCM integrates multiple DCE-derived parameter maps and identifies tumour regions with unique pharmacokinetic characteristics. Using this approach, a decision tree model using criteria beyond size to predict tumour grade in T1b ccRCCs is proposed. Key Points • Tumour size did not correlate with tumour grade in T1b ccRCC.
Introduction
Kidney cancer is the tenth most common cancer in humans, with an estimated 62,700 new cases and 14,240 deaths in the U.S. in 2016 [1] . More than 90% of kidney cancers are renal cell carcinomas (RCCs) and about 70% of these are clear cell RCC (ccRCC) [1] . The serendipitous discovery of RCC has been steadily increasing with the proliferation of crosssectional imaging studies [2] . However, the resultant increased detection of early stages has not translated into reduction of cancer-specific mortality, possibly indicating the overtreatment of small, potentially indolent renal tumours [3] . Consequently, active surveillance has become an acceptable option for the management of patients with incidentally discovered small renal masses (i.e. T1a disease) [4] . Although the risk of developing metastases for these patients is small, it increases in larger and high-grade tumours [5] . Similarly, ccRCC carries a worse prognosis than other pathological subtypes with lower prevalence, such as papillary and chromophobe RCCs [6] . The association between clear-cell histology and worse prognosis has not been specifically documented for T1b tumours, although a higher tumour grade is associated with worse disease-free survival of these tumours [7] . Furthermore, while the safety of active surveillance in T1b RCC has been reported [8] , the reliability of tumour biopsies to accurately grade RCC may be limited in larger, heterogeneous tumours and its role in providing an accurate histological subtype and nuclear grade may be limited [9, 10] . The lack of reliable predictors of oncological behaviour represent an important argument for resistance to using active surveillance, particularly in patients with larger, heterogeneous renal masses (T1b disease) [8, 11] . An imaging biomarker could help overcome this limitation by offering complementary information about tumour biology/aggressiveness in the whole tumour in patients with larger (T1b), heterogeneous, biopsyconfirmed ccRCCs. Multiphasic contrast-enhanced magnetic resonance imaging (MRI) can help in the characterisation of RCC subtypes based on the degree of enhancement [12] [13] [14] . Alternatively, a high temporal resolution dynamic contrast-enhanced (DCE) MRI approach combined with pharmacokinetic modelling of signal intensity allows for quantitative assessment of tumour vascularity with extraction of parameters such as the transfer constant between the intravascular and extravascular space (K trans ), the rate constant (K ep ) and the fractional volume of the extravascular extracellular (Ve) and vascular (Vp) space [15] [16] [17] [18] [19] . Efforts to correlate DCE MRI-derived pharmacokinetic parameters to tumour grade in RCC have offered variable results to date [16, 20] . Furthermore, the integration of large amounts of data generated in quantitative model-based pharmacokinetic maps challenges the applicability of tumour characterisation with DCE MRI in clinical practice. Moreover, it is unclear if such model-based quantitative parameters offer additional information compared to other simpler semiquantitative measures based on enhancement changes (e.g. initial area under the concentration curve [iAUC]). Clustering algorithms such as fuzzy c-means (FCM) of DCE-MRI data have been proved to be a useful tool in segmenting tissues in kidney [21] and to characterise and assess treatment response in heterogeneous tumours in the breast [22, 23] and brain [24] . To our knowledge, the value of pattern recognition techniques based on FCM algorithms to distinguish RCC grades has not been reported.
The purpose of this preliminary study was to apply a statistical clustering algorithm to combine information from multiple quantitative pharmacokinetic maps derived from DCE MRI to generate a single tumour map for the diagnosis of high-grade T1b ccRCC.
Materials and methods

Patient population
This was an Institutional Review Board approved, Health Insurance Portability and Accountability Act-compliant prospective study. Inclusion criteria: (1) patients with a known renal mass confined to the kidney that is >4 cm but ≤7 cm in size, (2) scheduled for surgical resection, (3) agreed to undergo a research MRI prior to surgery, and (4) histopathological confirmation of clear cell histology with pathological stage T1b after nephrectomy. All patients signed an informed consent prior to the MRI examination. Exclusion criteria: (1) patients with predominantly cystic masses on MRI (i.e. more than 75% of the mass demonstrating non-enhancing fluid signal with a thin wall), (2) (Fig. 1) . Data from DCE MRI acquisitions for these patients was previously reported but the analysis and results of the data of the previous report do not overlap with this analysis [25] .
MRI protocol
All patients underwent MRI on a 3-T dual-transmit MRI scanner with phased-array torso coils (Achieva and Ingenia; Philips Healthcare, Best, The Netherlands) before surgery (average MRI surgery time = 4 ± 3 days). A multiparametric MRI protocol included T2-weighted imaging for anatomic localisation with the following imaging parameters: echo time (TE)/repetition time (TR) = 80/1,115 ms, flip angle (FA) = 90 o , number of signal averages (NSA) = 1, field of view (FOV) = 402 × 340 mm 2 , acquisition matrix = 284 × 268, bandwidth = 467 Hz per pixel. DCE MRI was performed using a coronal three-dimensional (3D) spoiled gradient echo (SPGR) sequence before, during and after the administration of a bolus of 0.1 mmol/kg body weight of gadobutrol (Gadavist; Bayer Healthcare Pharmaceuticals, Wayne, NJ, USA) at a rate of 2 mL/s, followed by a 20-mL saline flush at 2 mL/s. A slightly slower injection rate than previously reported was used to compensate for the lower temporal resolution of the 3D acquisition and the high flow rate anticipated in the kidney and ccRCC. DCE images were acquired for about 6 min at 5 s per dynamic phase with the following parameters: TR/TE = 3/1.53 ms, FA = 10 o , NSA = 1, slice thickness = 5 mm, FOV = 180 x 408 mm 2 , acquisition matrix =120 × 288, bandwidth = 1,326 Hz per pixel. To minimise respiratory motion, three consecutive dynamic phases (5 s each) were obtained within each 15-s breath-held acquisition period with a 15-s period of free-breathing between consecutive acquisition periods. Prior to the DCE acquisition, three coronal SPGR acquisitions with the same image parameters as those described above but with flip angles of 2, 5 and 10 degrees, respectively, were obtained for the purpose of calculating tissue T1 relaxation [25] .
Image analysis
Only DCE-MRI data were included for the purpose of this study. DCE images were analysed with a commercial software, VersaVue Enterprise (iCAD, Nashua, NH, USA) with voxel by voxel fitting of the change of contrast agent concentration in tumour using the extended Tofts model. Quantitative maps of K trans and K ep were generated after motion correction using a non-rigid registration algorithm in VersaVue software [26] in 18 patients. A population-based arterial input function (AIF) [27] was used since the temporal resolution of the 3D DCE acquisition used in this study precluded the accurate measurement of individual AIF. The initial area under the concentration curve (iAUC) was calculated for 60 s after contrast arrival [28, 29] .
All DCE images and parametric maps were analysed using an open-source Picture Archiving and Communications System (PACS) viewer (OsiriX, version 5.6, 64-bit; Pixmeo, Geneva, Switzerland). A representative slice location through the centre of the mass was selected by a radiologist (I.P., more than 15 years of experience) who was unaware of the final pathology. Regions of interest (ROIs) were drawn by the same radiologist to outline the periphery of the target lesion. Pixel-by-pixel values of K trans , K ep and iAUC of the tumour ROI were exported for FCM clustering analysis. The maximum dimension in the supero-inferior direction (SI), latero-lateral direction (LL) and anterior-posterior direction (AP) was recorded. Three tumour size measurements on each renal mass were made: (1) maximum length (Length max ) of the tumour (cm) in the AP, LL, or SI dimension; (2) tumour area within a region of interest (ROI) drawn to outline the periphery of the renal mass (Area roi ); (3) estimated tumour volume (Vol est ) as SI x LL x AP. Further, we generated a surrogate of tumour shape by calculating the standard deviation of the lengths from AP, SI and LL. A round shaped tumour would have similar dimensions in all three orthogonal planes thus having a small shape measurement. An elliptical tumour would have a larger shape measurement since the differences among the dimensions were larger.
FCM clustering
Pixels within the tumour ROI in the representative slices from all patients were exported together and used for clustering (see below). Their DCE-derived parameters, K trans , K ep and iAUC, were recorded. All values were logarithmically transformed to correct for right skewness. Due to positive correlation between DCE-derived parameters, three clusters were used to classify different regions. They were named as low-active area (LAA), medium-active area (MAA) and high-active area (HAA). An FCM algorithm was then applied to the parameter domain with the number of clusters set at three [30] . The initial cluster centres were set such that the centre for LAA had lower K , highest K ep and highest iAUC (i.e. 75th percentile for HAA). The FCM algorithm recursively calculates between two steps until the objective function is minimised: step 1-calculate the membership to each data point corresponding to each cluster centre based on distance between the cluster centre and the data point; step 2-calculate the cluster centres as the weighted summation of the data points where the membership was used as weights. The objective function is the weighted summation of the distances between all points and all cluster centres with the membership as the weight. For each point, its membership to each of the three clusters are represented by three numbers between 0 and 1. These numbers can also be interpreted as the probability of belonging to each of the clusters. Therefore, the summation of the three memberships should be one for each point. After the objective function is minimised, each point is assigned to the cluster with the highest membership. The assigned cluster labels are then mapped back to the tumour ROIs.
Histopathological analysis
Histopathological results after surgical resection of the tumour served as the reference standard in all cases. The final diagnosis was provided by an uropathologist (more than 10 years of experience). All tumours were classified based on the International Society of Urological Pathology (ISUP) grading system as lowgrade ccRCC (ISUP I-II) or high-grade ccRCC (ISUP III-IV). The presence of necrosis at histopathology was recorded.
Statistical analysis
First, the percentages of LAA, MAA and HAA in each tumour were calculated (noted as %LAA, %MAA and %HAA). Second, the differences in the median of each tumour percentage area as well as the tumour size measurements between high-grade and low-grade ccRCCs were tested using Wilcoxon rank sum test univariately. The presence of necrosis at histopathology was also compared to tumour size and percentage areas.
Third, using tumour histopathology as reference, a binary decision-tree model was constructed and tested to identify a strategy to best classify the tumours based on the variables calculated above [31] . Briefly, a binary decision-tree model first ranks all variables according to their correlation to the reference (known as importance). The candidate variables included: (1) tumour size measurements (Length max , Area roi , Vol est and shape); (2) tumour activity measurements from FCM (% LAA, % MAA and % HAA); (3) tumour pharmacokinetic parameters (mean and standard deviation of K ep , K trans and iAUC). Then, the model selected a subset of the candidate variables and built a set of hierarchical rules that best discriminates high-grade and low-grade ccRCCs. Subsequently, the data are split into two sub-groups according to the variable with the highest importance and a cut-off that optimises the overall accuracy (node). This procedure is repeated for each of the sub-groups until a minimum size is reached or no improvement can be made. The minimum size for terminal node was set to 5 to avoid overfitting. To minimise the bias created by training and validating the model using the same data, a leave- [32] . The purpose was to train the decision tree on all but one tumour in the dataset, and compare the prediction of the tumour that was Bleft out^to its final histopathology diagnosis. This routine was repeated for each tumour in the data set, and the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were calculated. Ninety-five percent bootstrap confidence intervals were also calculated. A p value <0.05 was considered statistically significant. All statistical analyses were performed using the software, R (version 3.2.4, Vienna, Austria). The Rpart package was utilised for the construction of the decision-tree model.
Results
Eighteen patients (15 male, 3 female; mean age ± SD, 60 ± 8 years) were included in this study. Patients' characteristics are shown in Table 1 . Seven patients had high-grade and 11 patients had low-grade ccRCC. No significant difference was found in any of the size measurements between high-grade and low-grade ccRCCs ( Table 2 , Fig. 2 ). There was no statistical difference in mean length between tumours without (5.4 ± 0.9 cm) and with necrosis (6.4 ± 0.7 cm, p > 0.05).
FCM clustering
A total of 22,192 pixels were collected from all tumours. Pearson correlation coefficients were 0.75 between K ep and iAUC, 0.77 between K trans and iAUC, and 0.88 between K trans and K ep , which indicated strong positive correlation (i.e. pixels with higher K trans would also had higher K ep and higher iAUC). The FCM algorithm performed as expected with pixels from HAA exhibiting the highest values in all three DCE parameters, while pixels from LAA showed the lowest (Table 3) . Representative parametric and FCM maps are shown in Fig. 3 .
Median and mean ± standard deviation of percentage areas were 5.6% and 8.9% ± 8.8% (high grade) and 34.0% and 30.1% ± 17.9% (low grade) for %LAA; 42.8% and 40.1% ± 16.6% (high grade) and 37.7% and 40.2% ± 13.9% (low grade) for %MAA; and 53.6% and 51.1% ± 20.6% (high grade) and 19.6% and 29.8% ± 22.5% (low grade) for %HAA. Figure 4 gives a visual representation of the 
Decision-tree model
The optimal decision-tree model was constructed with selection of only one of the candidate variables, %HAA. According to the model, tumours were classified as low grade when %HAA < 27% and high grade when %HAA was ≥27%. An example in Fig. 5 illustrates how %HAA helps predicting tumour grade. After leave-one-out cross-validation, the accuracy, sensitivity, specificity, PPV and NPV for the diagnosis of high grade ccRCC were estimated as 78% (50%, 100%), 86% (66%, 100%), 73% (58%, 100%), 67% (56%, 100%) and 89% (63%, 100%).
Discussion
The implementation of active surveillance protocols for the management of small renal masses is based on the presumption that the risk of metastatic disease is minimal and likely lower than the morbidity and mortality associated with surgical and/or ablative interventions [33] [34] [35] . To minimise the risk of metastasis in active surveillance patients, most would advocate for tumour subtyping and grading with percutaneous biopsy at the time of diagnosis to rule out high-grade disease. However, this approach is not without limitations as serious complications associated to percutaneous biopsies occur in approximately 2-4% of patients [36, 37] . Importantly, incorrect tumour grading on percutaneous biopsies may occur in up to 30% of the renal masses sampled [37] and likely more common in larger, heterogeneous tumours. The inability to accurately grade the latter (i.e. T1b renal masses) is an obstacle towards implementation of active surveillance in patients with larger tumours despite evidence indicating that active surveillance for many of these may be indeed safe [8] . This is particularly relevant in the case of clear-cell histology given its association with worse prognosis and the inherent tumour heterogeneity that characterises this disease [38] . Our preliminary results suggest that a DCE-MRI protocol may add valuable information to the pre-surgical characterisation of T1b ccRCC.
Traditionally, the presence of intratumoural heterogeneity within a given tumour is not integrated into the analysis of imaging examinations performed for characterisation of renal masses, although the overall imaging phenotype is known to correlate with the final histopathological diagnosis [39] . However, the subjective nature of image interpretation leads to unreliable results because of differences in training, experience and other possible factors affecting decision-making. To Mean and standard deviation of iAUC, K ep and K trans stratified by active areas for all tumour pixels combined. High-active area had the highest values in all three DCE parameters while low-active area had the lowest values. maximise the utility of the acquired imaging data, statistical analyses such as histograms, probability distributions, spatial analyses and clustering have been introduced to quantify tumour heterogeneity and help improve diagnoses [40] [41] [42] [43] [44] . Our study introduces a novel approach by combining three DCE MRI-derived parameters to draw a simplified map of tumour vascular heterogeneity in ccRCC. The FCM algorithm offers a possibility to summarise multiple DCE-derived pharmacokinetic maps and identify unique tumour regions with different enhancement characteristics.
Tumour size measurements were not helpful in differentiating high-grade from low-grade ccRCCs in our study. This is consistent with previous reports illustrating the association between age, sex and size with increased risk of malignancy but moderate diagnostic performance of preoperative tools (e.g. nomograms) based on these variables for the prediction of tumour grade [45] . Our proposed decision-tree model had an overall accuracy, sensitivity, specificity, PPV and NPV for the diagnosis of high-grade ccRCC of 78%, 86%, 73%, 67% and 89%, respectively. These preliminary results, if validated in larger series, could have immediate clinical applicability in patients with inconclusive tumour grading (e.g. scant tissue) on percutaneous biopsy and those where the biopsy may be challenging based on the tumour location. Based on its high negative NPV (89%), DCE MRI may serve as a complementary test to percutaneous biopsy when selecting patients with heterogeneous T1b renal masses for active surveillance. Moreover, the statistical association between the percentage of HAA and high-grade histology suggests that directing percutaneous biopsies to those areas of the tumour with HAA could yield a higher diagnostic performance for the detection of its more aggressive component. Prior reports have demonstrated an ability of different MRI techniques such as arterial spin labelled perfusion, DCE MRI and diffusion-weighted imaging to detect intratumoural heterogeneity of microvessel density and tumour cellularity [15, 46] . Implementation of the proposed DCE MRI protocol as a screening method with the potential to replace percutaneous biopsy to identifying high-grade ccRCC would require a high sensitivity and NPV. In our cohort, with cross-validation adjustment, the overall sensitivity and NPVof the resulting tree were 86% and 89%, respectively. Thus, 11% of tumours classified as LG would than tumour 2 (Length max = 4.8 cm), which has a high %HAA (55%, maroon on FCM). The decision tree predicted low-grade histology for tumour 1 and high grade for tumour 2, respectively. Histopathological analysis confirmed the results of the decision-tree model with ccRCC ISUP grade II and III for tumour 1 and 2, respectively be misclassified. While encouraging, these results would indicate that percutaneous biopsy is still preferable in most clinical scenarios. However, with further refinements of this model (e.g. wholetumour assessment), it could potentially replace the percutaneous biopsy in carefully selected clinical scenarios, such as in patients with other comorbidities, and those with difficult access and/or inherent increased risk of complications.
Our study has several limitations. First, although we have pathological confirmation in all cases, a correlation between tumour heterogeneity on DCE MRI and at histopathology was not performed. In addition, because of the small sample size, we did not have any grade 4 RCCs. Second, our information on tumour vascularity was limited to K trans , K ep and iAUC. We did not include other parametric variables such as Ve and Vp into our study due to their high noise level. Third, the FCM algorithm provides information about each pixel behaviour during the DCE-MRI experiment but it does not take into account information about the location of the pixels. For this reason, we were not able to quantify spatial heterogeneity patterns similar to those in previous reports [43, 44] . Fourth, the confidence interval of the diagnostic performance was wide due to small sample size. Thus, the generalisability of this method needs to be tested on a larger dataset. Finally, we only analysed a single slice location through the centre of the mass for each of the DCE parametric maps. Analysis of multiple slices covering the entire renal mass may enhance the assessment of tumour heterogeneity. We chose a single-slice analysis based on the practicality of implementing this type of analysis in routine clinical practice. While expansion from 2D to 3D statistical models deserves further investigation, we anticipate that implementation of the latter would be more challenging (i.e. need to draw multiple ROIs per tumour and substantial increase in computation power needs).
In conclusion, the application of the FCM method to the DCE MRI data could facilitate the implementation of DCE MRI protocols in clinical practice by offering a single map that can be generated in seconds and be easily analysed in the context of an MRI exam performed for evaluation of a renal mass. The proposed statistical method offers an objective, quantitative analysis with the potential to offer meaningful information about the tumour biology in patients. Using this approach, we were able to construct a decision-tree model to predict tumour grade in T1b renal masses. Further validation of our preliminary results with this novel statistical method in larger patient cohorts is needed.
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